FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296801330> ?p ?o ?g. }

• W4296801330 endingPage "10296" @default.
• W4296801330 startingPage "10296" @default.
• W4296801330 abstract "The present study sought to establish the mitotically stable adult cutaneous fibroblast cell (ACFC) lines stemming from hFUT2×hGLA×HLA-E triple-transgenic pigs followed by trichostatin A (TSA)-assisted epigenetically modulating the reprogrammability of the transgenes permanently incorporated into the host genome and subsequent comprehensive analysis of molecular signatures related to proteomically profiling the generated ACFC lines. The results of Western blot and immunofluorescence analyses have proved that the profiles of relative abundance (RA) noticed for both recombinant human α-galactosidase A (rhα-Gal A) and human leukocyte antigen-E (HLA-E) underwent significant upregulations in tri-transgenic (3×TG) ACFCs subjected to TSA-mediated epigenetic transformation as compared to not only their TSA-unexposed counterparts but also TSA-treated and untreated non-transgenic (nTG) cells. The RT-qPCR-based analysis of porcine tri-genetically engineered ACFCs revealed stable expression of mRNA fractions transcribed from hFUT2, hGLA and HLA-E transgenes as compared to a lack of such transcriptional activities in non-transgenic ACFC variants. Furthermore, although TSA-based epigenomic modulation has given rise to a remarkable increase in the expression levels of Galα1→3Gal (α-Gal) epitopes that have been determined by lectin blotting analysis, their semi-quantitative profiles have dwindled profoundly in both TSA-exposed and unexposed 3×TG ACFCs as compared to their nTG counterparts. In conclusion, thoroughly exploring proteomic signatures in such epigenetically modulated ex vivo models devised on hFUT2×hGLA×HLA-E triple-transgenic ACFCs that display augmented reprogrammability of translational activities of two mRNA transcripts coding for rhα-Gal A and HLA-E proteins might provide a completely novel and powerful research tool for the panel of further studies. The objective of these future studies should be to multiply the tri-transgenic pigs with the aid of somatic cell nuclear transfer (SCNT)-based cloning for the purposes of both xenografting the porcine cutaneous bioprostheses and dermoplasty-mediated surgical treatments in human patients." @default.
• W4296801330 created "2022-09-24" @default.
• W4296801330 creator A5005219504 @default.
• W4296801330 creator A5023436858 @default.
• W4296801330 creator A5027878407 @default.
• W4296801330 creator A5035798165 @default.
• W4296801330 creator A5039540008 @default.
• W4296801330 creator A5050481244 @default.
• W4296801330 creator A5058592148 @default.
• W4296801330 creator A5060699777 @default.
• W4296801330 creator A5064337479 @default.
• W4296801330 creator A5006396816 @default.
• W4296801330 date "2022-09-07" @default.
• W4296801330 modified "2023-10-16" @default.
• W4296801330 title "The Relative Abundances of Human Leukocyte Antigen-E, α-Galactosidase A and α-Gal Antigenic Determinants Are Biased by Trichostatin A-Dependent Epigenetic Transformation of Triple-Transgenic Pig-Derived Dermal Fibroblast Cells" @default.
• W4296801330 cites W1618744733 @default.
• W4296801330 cites W1971574556 @default.
• W4296801330 cites W1972215343 @default.
• W4296801330 cites W1979273031 @default.
• W4296801330 cites W1981648522 @default.
• W4296801330 cites W1987706787 @default.
• W4296801330 cites W1990757073 @default.
• W4296801330 cites W2003831877 @default.
• W4296801330 cites W2012809827 @default.
• W4296801330 cites W2014208459 @default.
• W4296801330 cites W2015388866 @default.
• W4296801330 cites W2053593695 @default.
• W4296801330 cites W2057713397 @default.
• W4296801330 cites W2079482424 @default.
• W4296801330 cites W2079896286 @default.
• W4296801330 cites W2082687736 @default.
• W4296801330 cites W2088040832 @default.
• W4296801330 cites W2108244474 @default.
• W4296801330 cites W2110553915 @default.
• W4296801330 cites W2119139969 @default.
• W4296801330 cites W2129577579 @default.
• W4296801330 cites W2148591507 @default.
• W4296801330 cites W2168761262 @default.
• W4296801330 cites W2259697861 @default.
• W4296801330 cites W2415648752 @default.
• W4296801330 cites W2423888965 @default.
• W4296801330 cites W2464753108 @default.
• W4296801330 cites W2580414073 @default.
• W4296801330 cites W2734381510 @default.
• W4296801330 cites W2770284256 @default.
• W4296801330 cites W2778563384 @default.
• W4296801330 cites W2791278569 @default.
• W4296801330 cites W2889900538 @default.
• W4296801330 cites W2896714620 @default.
• W4296801330 cites W2958357534 @default.
• W4296801330 cites W2961936332 @default.
• W4296801330 cites W2988858857 @default.
• W4296801330 cites W3003099222 @default.
• W4296801330 cites W3007387080 @default.
• W4296801330 cites W3036018643 @default.
• W4296801330 cites W3092364740 @default.
• W4296801330 cites W3126139567 @default.
• W4296801330 cites W3127978946 @default.
• W4296801330 cites W3197908344 @default.
• W4296801330 cites W4211100043 @default.
• W4296801330 cites W804149696 @default.
• W4296801330 doi "https://doi.org/10.3390/ijms231810296" @default.
• W4296801330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36142211" @default.
• W4296801330 hasPublicationYear "2022" @default.
• W4296801330 type Work @default.
• W4296801330 citedByCount "7" @default.
• W4296801330 countsByYear W42968013302023 @default.
• W4296801330 crossrefType "journal-article" @default.
• W4296801330 hasAuthorship W4296801330A5005219504 @default.
• W4296801330 hasAuthorship W4296801330A5006396816 @default.
• W4296801330 hasAuthorship W4296801330A5023436858 @default.
• W4296801330 hasAuthorship W4296801330A5027878407 @default.
• W4296801330 hasAuthorship W4296801330A5035798165 @default.
• W4296801330 hasAuthorship W4296801330A5039540008 @default.
• W4296801330 hasAuthorship W4296801330A5050481244 @default.
• W4296801330 hasAuthorship W4296801330A5058592148 @default.
• W4296801330 hasAuthorship W4296801330A5060699777 @default.
• W4296801330 hasAuthorship W4296801330A5064337479 @default.
• W4296801330 hasBestOaLocation W42968013301 @default.
• W4296801330 hasConcept C102230213 @default.
• W4296801330 hasConcept C104317684 @default.
• W4296801330 hasConcept C141035611 @default.
• W4296801330 hasConcept C147483822 @default.
• W4296801330 hasConcept C153911025 @default.
• W4296801330 hasConcept C195616568 @default.
• W4296801330 hasConcept C2777865847 @default.
• W4296801330 hasConcept C2778305200 @default.
• W4296801330 hasConcept C41091548 @default.
• W4296801330 hasConcept C54355233 @default.
• W4296801330 hasConcept C64927066 @default.
• W4296801330 hasConcept C85265743 @default.
• W4296801330 hasConcept C86803240 @default.
• W4296801330 hasConceptScore W4296801330C102230213 @default.
• W4296801330 hasConceptScore W4296801330C104317684 @default.
• W4296801330 hasConceptScore W4296801330C141035611 @default.
• W4296801330 hasConceptScore W4296801330C147483822 @default.
• W4296801330 hasConceptScore W4296801330C153911025 @default.
• W4296801330 hasConceptScore W4296801330C195616568 @default.

• next